Singapore: Takeda Pharmaceutical has established the Global Medical Affairs Japan Department at Takeda Development Cente...
Singapore: Zeria Pharmaceutical and Astellas Pharma announced that, Zeria has obtained the marketing approval of Acofid...
International pharmaceutical R&D and manufacturing conference and expo, the 25th Interphex Japan, concluded on a suc...
Singapore: Daiichi Sankyo has launched TaNeDS (Take a New challenge for Drug diScovery) collaborative drug discovery pro...
Singapore: The Shimadzu Global Pharma Summit 2012 held in Singapore sent out an unaninmous message that it is high time ...
Singapore: Scotland's health technology assessment body, Scottish Medicines Consortium (SMC), has approved Eisai's AMPA ...
Singapore: Japanese drugmaker Daiichi Sankyo, which currently holds a majority stake in Ranbaxy, had earlier highlighted...
Singapore: Japan-based global analytics technology provider, Shimadzu, has launched i-Series of new industry standard HP...
Singapore: Japanese company Daiichi Sankyo has received positive results for a double-blind randomized phase III trial c...
Singapore: UCL (University College London) and Japan based Takeda Pharmaceutical have formed a new research collaboratio...
Singapore: Canadian company Opsens signed its first major agreement granting distribution and other rights for its OptoW...
Singapore: A*STAR's Institute for Infocomm Research (I2R), and Topcon Corporation, Japan based ophthalmic instruments an...
Singapore: Omron Healthcare has launched a new wireless sleep monitoring device in Japan that uses ResMed's technology a...
Singapore: Otsuka Pharmaceutical and H Lundbeck announced the US Food and Drug Administration (FDA) has approved ABILIF...
Singapore: Takeda Pharmaceutical and Advinus Therapeutics jointly announced that they would be initiating a three-year d...
Hyderabad: Fujifilm and Dr Reddy's Laboratories have decided to terminate the memorandum of understanding (MoU) to enter...
Singapore: Takeda Pharmaceutical announced the appointment of new senior leadership as well as the establishment of a ne...
Singapore: Japan based-Taiho Pharmaceutical is starting global phase III clinical trial (RECOURSE) for the novel combina...
